Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Impact of 5 Years of Liraglutide Treatment on Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus in a Real-Life Setting in Italy: An Observational Study.
Frison V, Simioni N, Marangoni A, Balzano S, Vinci C, Zenari L, De Moliner L, Tadiotto F, D'Ambrosio M, Confortin L, Marin N, Lombardi S, Costa S, Prosperini G, Lapolla A. Frison V, et al. Among authors: tadiotto f. Diabetes Ther. 2018 Dec;9(6):2201-2208. doi: 10.1007/s13300-018-0503-4. Epub 2018 Sep 20. Diabetes Ther. 2018. PMID: 30238228 Free PMC article.
Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
Lapolla A, Frison V, Bettio M, Dal Pos M, Rocchini P, Panebianco G, Tadiotto F, Da Tos V, D'Ambrosio M, Marangoni A, Ferrari M, Pianta A, Balzano S, Confortin L, Lamonica M, Marin N, Strazzabosco M, Brun E, Mesturino CA, Simoncini M, Zen F, Bax G, Bonsembiante B, Cardone C, Dal Frà MG, Gallo A, Masin M, Piarulli F, Sartore G, Simioni N. Lapolla A, et al. Among authors: tadiotto f. Clin Ther. 2015 Mar 1;37(3):574-84. doi: 10.1016/j.clinthera.2014.11.015. Epub 2015 Jan 24. Clin Ther. 2015. PMID: 25626486
Trend 2010-2018 in the clinical use of GLP-1 receptor agonists for the treatment of type 2 diabetes in routine clinical practice: an observational study from Northeast Italy.
Fadini GP, Frison V, Rigato M, Morieri ML, Simioni N, Tadiotto F, D'Ambrosio M, Paccagnella A, Lapolla A, Avogaro A. Fadini GP, et al. Among authors: tadiotto f. Acta Diabetol. 2020 Mar;57(3):367-375. doi: 10.1007/s00592-019-01445-z. Epub 2019 Oct 31. Acta Diabetol. 2020. PMID: 31673896
Fixed versus flexible combination of GLP-1 receptor agonists with basal insulin in type 2 diabetes: A retrospective multicentre comparative effectiveness study.
Morieri ML, Rigato M, Frison V, Simioni N, D'Ambrosio M, Tadiotto F, Paccagnella A, Lapolla A, Avogaro A, Fadini GP. Morieri ML, et al. Among authors: tadiotto f. Diabetes Obes Metab. 2019 Nov;21(11):2542-2552. doi: 10.1111/dom.13840. Epub 2019 Aug 12. Diabetes Obes Metab. 2019. PMID: 31364233 Free PMC article.
Changes in markers of hepatic steatosis and fibrosis in patients with type 2 diabetes during treatment with glucagon-like peptide-1 receptor agonists. A multicenter retrospective longitudinal study.
Morieri ML, Targher G, Lapolla A, D'Ambrosio M, Tadiotto F, Rigato M, Frison V, Paccagnella A, Simioni N, Avogaro A, Fadini GP. Morieri ML, et al. Among authors: tadiotto f. Nutr Metab Cardiovasc Dis. 2021 Nov 29;31(12):3474-3483. doi: 10.1016/j.numecd.2021.08.049. Epub 2021 Sep 9. Nutr Metab Cardiovasc Dis. 2021. PMID: 34629258
Mechanisms of acute and chronic hypoglycemic action of gliclazide.
da Tos V, Maran A, Vigili de Kreutzenberg S, Marchetto S, Tadiotto F, Bettio M, Marescotti MC, Tiengo A, Del Prato S. da Tos V, et al. Among authors: tadiotto f. Acta Diabetol. 2000;37(4):201-6. doi: 10.1007/s005920070006. Acta Diabetol. 2000. PMID: 11450504 Clinical Trial.
24 results